[Federal Register Volume 69, Number 248 (Tuesday, December 28, 2004)]
[Notices]
[Page 77788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-28473]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Artec, Inc.; Order of Suspension of Trading

December 23, 2004.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Artec, Inc. (``ATKJ'') because of questions regarding the accuracy of 
assertions by ATKJ and others, on ATKJ's Web site, in ATKJ's press 
releases, and in public statements to investors concerning, among other 
things, the testing of ATKJ's Tubercin substance for use in treating 
cancer patients.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the above listed 
company is suspended for the period from 9:30 a.m. e.s.t. December 23, 
2004 through 11:59 p.m. e.s.t., on January 7, 2005.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 04-28473 Filed 12-23-04; 11:55 am]
BILLING CODE 8010-01-P